The impact of analytic method on interpretation of outcomes in longitudinal clinical trials
about
Evaluation of a tailored implementation strategy to improve the management of patients with chronic obstructive pulmonary disease in primary care: a study protocol of a cluster randomized trialAdd-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.Effects of drop-out on efficacy estimates in five Cochrane reviews of popular antipsychotics for schizophrenia.Self-Help for Depression via E-mail: A Randomised Controlled Trial of Effects on Depression and Self-Help Behaviour.Analgesic efficacy of opioids in chronic pain: recent meta-analysesShould we treat depression with drugs or psychological interventions? A reply to Ioannidis.Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatientsPost-treatment outcomes in a double-blind, randomized trial of sertraline for alcohol dependenceStructural models describing placebo treatment effects in schizophrenia and other neuropsychiatric disorders.The efficacy of vortioxetine for the treatment of major depressive disorder.Choice of estimand and analysis methods in diabetes trials with rescue medication.A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.Efficacy of antidepressants: bias in randomized clinical trials and related issues.The predictive value of early response in patients with depressive disorders.Enhancing quality of life and mastery of informal caregivers of high-grade glioma patients: a randomized controlled trial.Parent-child interaction therapy: an evidence-based treatment for child maltreatment.
P2860
Q33597962-D0783297-A186-4CB0-BA23-848A1D4CD5B1Q33800161-410E3AD2-3315-4AC9-A876-0C871EC00752Q34266750-309308F1-287A-4266-A510-A4CF63A38ECDQ34785394-00EA8163-96C6-42D5-BB1F-BB3A4135E69BQ34939554-7C1E88A6-2B55-471E-B794-3017070335EAQ35069464-F4F1C25B-7CF1-4C97-9341-9F7B9A2F4550Q36024493-ED32112A-3B6D-4155-9E78-A426F08B12E1Q37040447-395D8096-7654-4B84-A9A9-D17609B5490FQ37886138-03C4A42D-134D-47D6-B01B-B09DA5581E3FQ38270790-9A1A2F14-D7AA-4D43-99F1-807C66AF32F0Q40576360-2EEA7BCC-478F-4391-835E-D2C786DC8C50Q47701023-B16B78D7-D57A-462D-B2BC-A51E4EE975F4Q47772123-4CEF6FE3-1D95-4E8B-A5E8-7BAF13768C18Q47912718-5ECC861E-8E2D-4899-A37E-B430C6098F97Q48266131-359262F8-7694-4AF3-8F60-1A111EB09AE9Q53107650-4746ECC3-7AEA-4BAB-A88B-D30745372EF5
P2860
The impact of analytic method on interpretation of outcomes in longitudinal clinical trials
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The impact of analytic method ...... n longitudinal clinical trials
@en
The impact of analytic method ...... longitudinal clinical trials.
@nl
type
label
The impact of analytic method ...... n longitudinal clinical trials
@en
The impact of analytic method ...... longitudinal clinical trials.
@nl
prefLabel
The impact of analytic method ...... n longitudinal clinical trials
@en
The impact of analytic method ...... longitudinal clinical trials.
@nl
P2093
P2860
P1476
The impact of analytic method ...... n longitudinal clinical trials
@en
P2093
C H Mallinckrodt
R C Risser
P2860
P304
P356
10.1111/J.1742-1241.2008.01808.X
P577
2008-06-28T00:00:00Z